Xcout Intel
Katalyze AI
Katalyze AI specializes in AI-enhanced biomanufacturing and optimizing ESG (Environmental, Social, and Governance) supply chain processes. The company's platform integrates cutting-edge AI technology to streamline these operations.
Subscribe to see Katalyze AI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Katalyze AI at a glance
Katalyze AI is an ai company. Its most recent funding round, Seed, raised $10.5M in July 2026.
Katalyze AI funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $10.5M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Katalyze AI news
Investors
Katalyze AI competitors
A few of Katalyze AI's closest competitors — see the full list of competitors and alternatives →
Vitalize is an AI platform headquartered in San Francisco, California, with 50 employees. The company provides software that unifies staffing, scheduling, flow, and capacity to help health systems optimize labor and operations.
B12 Labs provides an AI-powered software platform that automates and accelerates chemical synthesis for the pharmaceutical and biotechnology industries. Its tools assist researchers with retrosynthesis planning, reaction condition optimization, and the generation of execution-ready protocols for lab automation equipment.
Kyrok is a company headquartered in Berlin, Germany, focused on modernizing pharma supply chains. It develops AI supply chain agents for the pharmaceutical and chemical industries, aiming to bring AI to these sectors.
BIO-AI, Inc. develops AI-driven world models to simulate human biology across multiple scales. The company builds programmable virtual cells and a general-purpose cell biology simulator to accelerate research and discovery for medicine, biotechnology, and life sciences.
CuspAI develops AI-powered technology focused on materials discovery. The company provides tools and foundry integration sessions to help researchers and organizations identify and develop new materials.
MSKAi, LLC provides an artificial intelligence-based software platform designed for skeletal diagnostic digital imaging and musculoskeletal analysis. Its technology identifies, measures, and classifies spinal anatomy and pathologies to support pre-surgery authorizations, treatment assessments, and employee-injury risk evaluations for healthcare providers and employers.
Get Katalyze AI's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Katalyze AI? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Katalyze AI in Xcout Intel
- 1 funding round with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access